R. Mcmurray

Medical therapy for systemic lupus erythematosus.

Jason K. Taylor, R. Mcmurray, 2011, Journal of the Mississippi State Medical Association.

Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study

E. Trinka, S. Auvin, R. Shankar, 2023, Frontiers in Neurology.

PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice

B. Steinhoff, W. D’Souza, E. Trinka, 2021, Journal of Neurology.

Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practice

T. Maehara, J. Jacobs, T. Alsaadi, 2023, Epilepsia.

Novel seizure outcomes in patients with Lennox‐Gastaut syndrome: Post hoc analysis of seizure‐free days in rufinamide Study 303

S. Auvin, Dinesh Kumar, C. Perdomo, 2019, Epilepsia open.

Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.

P. Striano, M. Falip, E. Santamarina, 2018, Epileptic disorders : international epilepsy journal with videotape.

Real-world data on rufinamide treatment in patients with Lennox–Gastaut syndrome: Results from a European noninterventional registry study

S. Auvin, M. Nikanorova, C. Brandt, 2017, Epilepsy & Behavior.

Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients with partial onset seizures: Results of the observational study ZOOM

M. Baulac, H. Hamer, R. McMurray, 2016, Seizure.